{
    "code": "60001037",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001037",
    "time": "2020-02-26 09:59:33",
    "許可證字號": "衛部菌疫輸字第001037號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/02\/09",
    "發證日期": "106\/02\/09",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000103707",
    "中文品名": "保脂通注射劑75毫克",
    "英文品名": "Praluent solution for injection 75mg",
    "適應症": "對於已接受最高耐受劑量statin，但低密度脂蛋白膽固醇(LDL-C)仍無法達到目標值之異合子家族性高膽固醇血症(HeFH)或動脈粥狀硬化心血管疾病(clinical ASCVD)之成人患者，Praluent 可作為飲食外的輔助治療。\r\n\r\n對statin 不耐受或禁用statin 之原發性高膽固醇血症(異合子家族性及非家族性)或混合型血脂異常之成人患者，Praluent 可單獨或併用其他降血脂藥物，作為飲食外的輔助治療。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 1ml預填針筒 1ml注射筆",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 5F免除銜接性試驗",
        "申請商名稱": "1707201200  賽諾菲股份有限公司",
        "申請商地址": "台北市信義區松仁路3號7樓",
        "主製造廠": ""
    },
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FDE0273000  SANOFI-AVENTIS DEUTSCHLAND GMBH",
            "製造廠廠址": "BRUNINGSTRASSE 50,D-65926 FRANKFURT AM (MAIN) GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIE0035000  GENZYME IRELAND LIMITED",
            "製造廠廠址": "IDA INDUSTRIAL PARK, OLD KILMEADEN ROAD, WATERFORD, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FUS0332000  REGENERON PHARMACEUTICALS INC.",
            "製造廠廠址": "81 COLUMBIA TURNPIKE RENSSELAER NY 12144 U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406004600",
            "成分名稱": "Alirocumab",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "108.04.26-保脂通 仿單+使用手冊(600x378mm) 201907 importing-108-07-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=005&Type=9"
        },
        {
            "title": "Praluent 75_LPI_Ｃ_SmPC+CCDS v3, v4+ToR + KT study_TFDA comment 2018.08.15 clean-107-08-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=004&Type=9"
        },
        {
            "title": "Praluent 75mg pen中文使用手冊-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=003&Type=9"
        },
        {
            "title": "Praluent 75mg syringe中文使用手冊-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=002&Type=9"
        },
        {
            "title": "pen 外盒 一隻裝 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=005&Type=8"
        },
        {
            "title": "pen 標籤 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=004&Type=8"
        },
        {
            "title": "syringe 外盒 一隻裝 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=003&Type=8"
        },
        {
            "title": "syringe 標籤 75mg-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=002&Type=8"
        },
        {
            "title": "中文標籤-106-02-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001037&Seq=001&Type=8"
        }
    ]
}